General Information of Drug Combination (ID: DCR8D4X)

Drug Combination Name
Trientine Hydrochloride Penicillamine
Indication
Disease Entry Status REF
Wilson Disease Phase 3 [1]
Component Drugs Trientine Hydrochloride   DM0KCV1 Penicillamine   DM40EF6
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL is unavailable 3D MOL

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of Trientine Hydrochloride
Disease Entry ICD 11 Status REF
Wilson disease 5C64.00 Approved [2]
Indication(s) of Penicillamine
Disease Entry ICD 11 Status REF
Cystinuria 5C60.2 Approved [3]
Rheumatoid arthritis FA20 Approved [4]
Wilson disease 5C64.00 Investigative [3]
Penicillamine Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Human immunodeficiency virus Tat protein (HIV tat) TTT3ZC9 TAT_HV1H2 Inhibitor [6]
------------------------------------------------------------------------------------
Penicillamine Interacts with 24 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Elastin (ELN) OTFSO7PG ELN_HUMAN Affects Localization [7]
Collagen alpha-1(I) chain (COL1A1) OTI31178 CO1A1_HUMAN Increases ADR [8]
Eukaryotic translation initiation factor 2 subunit 1 (EIF2S1) OTM0GDTP IF2A_HUMAN Increases Phosphorylation [9]
Poly polymerase 1 (PARP1) OT310QSG PARP1_HUMAN Increases Cleavage [9]
C-C motif chemokine 3 (CCL3) OTW2H3ND CCL3_HUMAN Increases Expression [9]
C-C motif chemokine 4 (CCL4) OT6B8P25 CCL4_HUMAN Increases Expression [9]
Heat shock 70 kDa protein 6 (HSPA6) OTH4S7WB HSP76_HUMAN Increases Expression [9]
Glutathione S-transferase Mu 3 (GSTM3) OTLA2WJT GSTM3_HUMAN Increases Expression [9]
Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A) OTDRV63V GA45A_HUMAN Increases Expression [9]
Heat shock 70 kDa protein 1-like (HSPA1L) OTC2V1K6 HS71L_HUMAN Increases Expression [9]
DNA damage-inducible transcript 3 protein (DDIT3) OTI8YKKE DDIT3_HUMAN Increases Expression [9]
Flavin-containing monooxygenase 5 (FMO5) OTTILF8T FMO5_HUMAN Increases Expression [9]
Heat shock-related 70 kDa protein 2 (HSPA2) OTSDET7B HSP72_HUMAN Increases Expression [9]
Flavin-containing monooxygenase 1 (FMO1) OTTHSQKP FMO1_HUMAN Increases Expression [9]
Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1) OTXEE550 APR_HUMAN Increases Expression [9]
Bcl-2-binding component 3, isoforms 3/4 (BBC3) OTUAXDAY BBC3B_HUMAN Decreases Expression [9]
High affinity copper uptake protein 1 (SLC31A1) OTXLRTUB COPT1_HUMAN Increases Expression [10]
C-reactive protein (CRP) OT0RFT8F CRP_HUMAN Decreases Expression [11]
Amyloid-beta precursor protein (APP) OTKFD7R4 A4_HUMAN Increases Metabolism [12]
Metallothionein-1X (MT1X) OT9AKFVS MT1X_HUMAN Decreases Expression [13]
MHC class I antigen (HLA-B) OTGPIQEH O19755_HUMAN Increases ADR [8]
MHC class I antigen HLA-B18 (HLA-B18) OTO1T7OA O77967_HUMAN Increases ADR [8]
HLA-DR4 protein (HLA-DR4) OTR8MHXB O77963_HUMAN Increases ADR [8]
HLA-DR3 (HLA-DRB1) OTZ84GNP Q29887_HUMAN Increases ADR [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 24 DOT(s)

References

1 ClinicalTrials.gov (NCT03539952) Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Penicillamine FDA Label
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7264).
5 N-acetyl cysteine and penicillamine induce apoptosis via the ER stress response-signaling pathway. Mol Carcinog. 2010 Jan;49(1):68-74. doi: 10.1002/mc.20578.
6 Docking studies reveal a selective binding of D-penicillamine to the transactivator protein of human immunodeficiency virus type 1. FEBS Lett. 2002 Apr 10;516(1-3):43-6.
7 Collagen and elastin changes in D-penicillamine-induced pseudoxanthoma elasticum-like skin. Br J Dermatol. 1986 Mar;114(3):381-8. doi: 10.1111/j.1365-2133.1986.tb02832.x.
8 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
9 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
10 Mechanistic basis for overcoming platinum resistance using copper chelating agents. Mol Cancer Ther. 2012 Nov;11(11):2483-94. doi: 10.1158/1535-7163.MCT-12-0580. Epub 2012 Aug 21.
11 The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis. Curr Med Res Opin. 1975;3(5):286-97. doi: 10.1185/03007997509114779.
12 Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease. J Struct Biol. 2000 Jun;130(2-3):209-16. doi: 10.1006/jsbi.2000.4285.
13 The effect of zinc and D-penicillamine in a stable human hepatoma ATP7B knockout cell line. PLoS One. 2014 Jun 3;9(6):e98809. doi: 10.1371/journal.pone.0098809. eCollection 2014.